{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:40:51Z","timestamp":1790311251524,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T00:00:00Z","timestamp":1326240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029615","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T21:45:26Z","timestamp":1326318326000},"page":"e29615","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":50,"title":["An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Manisha","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Blick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel R.","family":"Hardink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Waltham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik W.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10555-007-9089-4","article-title":"The other side of MMPs: protective roles in tumor progression.","volume":"26","author":"MD Martin","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref2","first-page":"85","article-title":"Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.","volume":"1785","author":"TJ Wilson","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","article-title":"Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.","volume":"6","author":"CM Overall","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjc.6603043","article-title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy.","volume":"94","author":"CM Overall","year":"2006","journal-title":"Br J Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-8-83","article-title":"Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.","volume":"8","author":"B Zhang","year":"2008","journal-title":"BMC Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10585-008-9202-2","article-title":"MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1.","volume":"25","author":"SL Kominsky","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.lungcan.2006.01.011","article-title":"Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.","volume":"52","author":"CP Hsu","year":"2006","journal-title":"Lung Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jcp.55.10.758","article-title":"Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.","volume":"55","author":"MF Leeman","year":"2002","journal-title":"J Clin Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/s10165-004-0292-7","article-title":"Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3).","volume":"14","author":"G Tardif","year":"2004","journal-title":"Mod Rheumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","article-title":"Stromal expression of MMP-13 is required for melanoma invasion and metastasis.","volume":"129","author":"P Zigrino","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ijc.20763","article-title":"Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.","volume":"114","author":"MA Lafleur","year":"2005","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"17192","DOI":"10.1073\/pnas.0407788101","article-title":"Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.","volume":"101","author":"M Inada","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1242\/dev.01461","article-title":"Altered endochondral bone development in matrix metalloproteinase 13-deficient mice.","volume":"131","author":"D Stickens","year":"2004","journal-title":"Development"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bone.2009.01.393","article-title":"Collagenase expression and activity in the stromal cells from giant cell tumour of bone.","volume":"44","author":"RW Cowan","year":"2009","journal-title":"Bone"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00240-004-0440-8","article-title":"Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.","volume":"33","author":"G Morgia","year":"2005","journal-title":"Urol Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.bjc.6600858","article-title":"Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis.","volume":"88","author":"T Ohshiba","year":"2003","journal-title":"Br J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1158\/0008-5472.CAN-09-3251","article-title":"Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.","volume":"70","author":"KC Nannuru","year":"2010","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"34271","DOI":"10.1074\/jbc.M111.222513","article-title":"Microarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.","volume":"286","author":"C Morrison","year":"2011","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1359\/jbmr.2000.15.7.1257","article-title":"Collagenase-3 (MMP-13) and integral membrane protein 2a (Itm2a) are marker genes of chondrogenic\/osteoblastic cells in bone formation: sequential temporal, and spatial expression of Itm2a, alkaline phosphatase, MMP-13, and osteocalcin in the mouse.","volume":"15","author":"JP Tuckermann","year":"2000","journal-title":"J Bone Miner Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2353\/ajpath.2009.081080","article-title":"MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing.","volume":"175","author":"N Hattori","year":"2009","journal-title":"Am J Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.21268","article-title":"Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.","volume":"44","author":"H Uchinami","year":"2006","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI10564","article-title":"Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice.","volume":"107","author":"LA Neuhold","year":"2001","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/08916930600807709","article-title":"The expression of collagenase 3 (MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis.","volume":"39","author":"D Wernicke","year":"2006","journal-title":"Autoimmunity"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/art.25002","article-title":"Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.","volume":"60","author":"CB Little","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/6657","article-title":"Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.","volume":"6","author":"B Lovejoy","year":"1999","journal-title":"Nat Struct Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bmcl.2005.02.038","article-title":"Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.","volume":"15","author":"JA Blagg","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.bmcl.2006.08.066","article-title":"Potent, selective pyrimidinetrione-based inhibitors of MMP-13.","volume":"16","author":"LA Reiter","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1541-7786.1.3.1","article-title":"Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.","volume":"3","author":"BL Eckhardt","year":"2005","journal-title":"Mol Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006689719505","article-title":"A novel orthotopic model of breast cancer metastasis to bone.","volume":"17","author":"M Lelekakis","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1023\/A:1011953118186","article-title":"MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.","volume":"18","author":"AM Tester","year":"2000","journal-title":"Clin Exp Metastasis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/B:CLIN.0000017167.17065.61","article-title":"Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.","volume":"21","author":"JA Sharp","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/A:1016381416463","article-title":"Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.","volume":"19","author":"AM Tester","year":"2002","journal-title":"Clin Exp Metastasis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/cncr.21530","article-title":"Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice.","volume":"104","author":"B Ory","year":"2005","journal-title":"Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/0008-5472.CAN-04-1622","article-title":"Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.","volume":"65","author":"L Udabage","year":"2005","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/002215540405200312","article-title":"Fluorescence-based staining for tartrate-resistant acidic phosphatase (TRAP) in osteoclasts combined with other fluorescent dyes and protocols.","volume":"52","author":"L Filgueira","year":"2004","journal-title":"J Histochem Cytochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-08-3949","article-title":"Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis.","volume":"69","author":"S Thiolloy","year":"2009","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2174\/138161207781039706","article-title":"Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors.","volume":"13","author":"E Nuti","year":"2007","journal-title":"Curr Pharm Des"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cardiores.2005.11.032","article-title":"The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors.","volume":"69","author":"JT Peterson","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.","volume":"282","author":"AR Johnson","year":"2007","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","article-title":"Biochemical characterization of human collagenase-3.","volume":"271","author":"V Knauper","year":"1996","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.284.5415.808","article-title":"Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.","volume":"284","author":"G Bergers","year":"1999","journal-title":"Science"},{"key":"ref42","first-page":"7091","article-title":"Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.","volume":"61","author":"BS Nielsen","year":"2001","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/carcin\/bgp248","article-title":"MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.","volume":"31","author":"W Lederle","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1371\/journal.pone.0001150","article-title":"Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration.","volume":"2","author":"DJ Behonick","year":"2007","journal-title":"PLoS ONE"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2010.06.007","article-title":"Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.","volume":"48","author":"CC Lynch","year":"2011","journal-title":"Bone"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.bone.2004.06.019","article-title":"A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.","volume":"35","author":"TL Andersen","year":"2004","journal-title":"Bone"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bone.2008.03.020","article-title":"Matrix metalloproteinases and bone.","volume":"43","author":"SM Krane","year":"2008","journal-title":"Bone"},{"key":"ref48","first-page":"2153","article-title":"Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3\u2032,5\u2032-monophosphate and requiring protein synthesis.","volume":"6","author":"DK Scott","year":"1992","journal-title":"Mol Endocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00517.2003","article-title":"Nmp4\/CIZ regulation of matrix metalloproteinase 13 (MMP-13) response to parathyroid hormone in osteoblasts.","volume":"287","author":"R Shah","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.","volume":"61","author":"JM Delaisse","year":"2003","journal-title":"Microsc Res Tech"},{"issue":"Pt 11","key":"ref51","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1242\/jcs.107.11.3055","article-title":"The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.","volume":"107","author":"PA Hill","year":"1994","journal-title":"J Cell Sci"},{"issue":"Pt 5","key":"ref52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1242\/jcs.110.5.589","article-title":"Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts.","volume":"110","author":"T Sato","year":"1997","journal-title":"J Cell Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0021-9258(17)42227-7","article-title":"Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.","volume":"269","author":"K Tezuka","year":"1994","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ctrv.2008.02.004","article-title":"Exploring the anti-tumour activity of bisphosphonates in early breast cancer.","volume":"34","author":"MC Winter","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"ref55","first-page":"3551","article-title":"Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.","volume":"55","author":"A Sasaki","year":"1995","journal-title":"Cancer Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(06)70726-4","article-title":"Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.","volume":"7","author":"CA Migliorati","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T13:38:03Z","timestamp":1686663483000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029615"}},"subtitle":[],"editor":[{"given":"Matthew","family":"Bogyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029615","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,11]]}}}